A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal

Trial Profile

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2015

At a glance

  • Drugs Bupivacaine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPROVE-IR
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
    • 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the World Congress of Enhanced Recovery after Surgery and Perioperative Medicine, Plastic Surgery Research Council (PSRC).
    • 26 Feb 2013 Official title amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top